Sisi Zhang

Title: Sisi Zhang - Innovator in Pharmaceutical Applications

Introduction

Sisi Zhang is an inventor based in Suzhou, China. He is focused on developing innovative pharmaceutical compounds aimed at treating various autoimmune diseases. Although he currently holds no granted patents, his work in the field of medicinal chemistry is noteworthy.

Latest Patent Applications

Sisi Zhang has submitted several patent applications, including:

1. **CRYSTALLINE FORMS OF A TLR7/TLR8 INHIBITOR** - This application relates to various crystalline forms of (S)—N-(4-((5-(1,6-dimethyl-1H-pyrazolo[3,4-b]pyridin-4-yl)-3-methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridin-1-yl)methyl)bicyclo[2.2.2]octan-1-yl)morpholine-3-carboxamide in its free form, as well as compositions, methods of making, and methods of using the same. In some embodiments, the crystalline forms also contain water ('hydrates'). These materials are useful in the treatment of various autoimmune diseases, including systemic lupus erythematosus, cutaneous lupus, discoid lupus, mixed connective tissue disease, primary biliary cirrhosis, immune thrombocytopenia purpura, hidradenitis suppurativa, dermatomyositis, polymyositis, Sjögren's syndrome, arthritis, rheumatoid arthritis, and psoriasis.

2. **Bicyclic Compounds and their Uses** - The present invention provides a compound, or a pharmaceutically acceptable salt thereof, of formula (I): wherein R, R, R, R, R, R, R, y, R, M, W, L, V, T, Y, J, K, and A are as described herein, therapeutic uses of said compounds, uses of said compounds as research chemicals, a pharmaceutical composition and combinations comprising said compounds, and methods for manufacturing the compounds of the invention.

Conclusion

Sisi Zhang is making significant strides in the field of pharmaceutical innovations, particularly in the treatment of autoimmune diseases. His latest patent applications reflect his commitment to advancing medical science through innovative compounds.